Suppr超能文献

[体外化疗(阿斯塔Z 7557)处理的骨髓自体移植用于巩固成人急性白血病首次完全缓解期]

[Autograft of bone marrow treated by in vitro chemotherapy (Asta Z 7557) for consolidation of acute leukemia in adults in the first complete remission].

作者信息

Laporte J P, Gorin N C, Douay L, Lopez M, Najman A, Stachowiak J, Aegerter P, Lemonnier M P, Pene F, Kantor G

出版信息

Presse Med. 1987 Feb 28;16(7):338-42.

PMID:2950482
Abstract

Fourteen adult patients in first complete remission of acute leukemia (A.L.) [6 with acute lymphoblastic leukemia (ALL), 8 with acute non lymphoblastic leukemia (ANLL)] were consolidated with high dose cyclophosphamide and total body irradiation followed by autologous bone marrow transplantation (ABMT) with marrow cleansed in vitro by Asta Z 7557. According to our previously described protocol showing evidence for a wide range of sensitivity from patient to patient, the marrow of each individual patient was incubated with the highest tolerable dose of Asta Z 7557. This dose, individually determined, was defined as the dose sparing between 0 and 10% of CFU-GM (CFU-GM DL95). ABMT was not followed by maintenance therapy. Hematological reconstitution was significantly faster in ALL patients when compared to ANLL patients. Out of these 14 patients: 2 relapsed on months 5 and 15 respectively after ABMT, and 2 died in complete remission on months 3 and 16 respectively, of veno-occlusive disease and encephalitis. Ten patients (70%) remain in complete remission up to a median of 15 months +, with 4 patients over 24 months +.

摘要

14例急性白血病(A.L.)首次完全缓解的成年患者[6例急性淋巴细胞白血病(ALL),8例急性非淋巴细胞白血病(ANLL)]接受了高剂量环磷酰胺和全身照射,随后进行自体骨髓移植(ABMT),骨髓在体外经阿斯塔Z 7557净化。根据我们先前描述的方案,该方案显示出患者之间存在广泛的敏感性差异,每位患者的骨髓都用阿斯塔Z 7557的最高耐受剂量进行孵育。这个单独确定的剂量被定义为使集落形成单位-粒细胞巨噬细胞(CFU-GM)减少0至10%的剂量(CFU-GM DL95)。ABMT后未进行维持治疗。与ANLL患者相比,ALL患者的血液学重建明显更快。在这14例患者中:2例分别在ABMT后第5个月和第15个月复发,2例分别在第3个月和第16个月因静脉闭塞性疾病和脑炎在完全缓解期死亡。10例患者(70%)持续完全缓解,中位缓解时间达15个月以上,4例患者缓解时间超过24个月以上。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验